GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Tax Provision

Lanzhou Foci Pharmaceutical Co (SZSE:002644) Tax Provision : ¥-3.4 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Lanzhou Foci Pharmaceutical Co Tax Provision?

Lanzhou Foci Pharmaceutical Co's tax provision for the three months ended in Sep. 2024 was ¥-0.5 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-3.4 Mil.

Lanzhou Foci Pharmaceutical Co Tax Provision Historical Data

The historical data trend for Lanzhou Foci Pharmaceutical Co's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lanzhou Foci Pharmaceutical Co Tax Provision Chart

Lanzhou Foci Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.81 -22.81 -17.30 -21.37 -13.52

Lanzhou Foci Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.09 1.85 -3.96 -0.77 -0.50

Lanzhou Foci Pharmaceutical Co Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-3.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lanzhou Foci Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lanzhou Foci Pharmaceutical Co Ltd (SZSE:002644) » Definitions » Tax Provision
Comparable Companies
SZSE:300158 SHSE:603998 SZSE:002793 SZSE:301277 SHSE:688373 SHSE:603676 SZSE:000919 SZSE:002728 SHSE:688221 SZSE:300110 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB HKSE:03692
Traded in Other Exchanges
N/A
Address
68 Foci Street ChangGuan Region, Lanzhou, CHN, 730046
Website
http://www.fczy.com
Lanzhou Foci Pharmaceutical Co Ltd is a pharmaceutical company based in China. The company is engaged in the production and sales of Chinese traditional medicine. In addition to manufacturing, the company also conducts research to develop new herbal drugs. Its product portfolio consists of concentrated pills, granules, hard capsules, concentrated decoctions and medicinal wine. The products of the company are exported to more than 27 countries including the United States, Canada, Japan, Australia, Russia, and Ukraine, among others.
Executives
Sun Yu Directors, executives
Su Wen Bo Supervisors
An Wen Ting Securities Affairs Representative

Lanzhou Foci Pharmaceutical Co Headlines

No Headlines